Vous êtes ici

Alternate Health Corp.

Liste d'échange: 
CSE
Statut: 
Suspended
Industrie: 
Life Sciences
Symbole: 
AHG
Indice CSE: 
Devise: 

Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the CBD industry, including extraction, product development and distribution. Alternate Health’s industry-leading software systems provide the platform for the company’s diverse operations, including blockchain tax collection systems, CBD product distribution, hemp-derived extract manufacturing and the first medial cannabis online portal approved by the Florida Department of Health.

T​​hrough Alternate Health’s subsidiary, Blaine Labs, the Company is a leader in cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health’s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders. For more information about Alternate Health Corp., visit www.alternatehealth.com.

Vous êtes ici

Alternate Health Corp. (AHG)

SEDAR Information

Information d'entreprise

Addresse
99 Yorkville Ave
Suite 200
Toronto, ON M5R 1C1
Canada
Téléphone
416.607.5757
Courriel
info@alternatehealth.ca
URL
http://alternatehealth.com
Date d’inscription à la cote
Jeudi, janvier 19, 2017
Agent de transfert
Computershare Investor Services Inc.
Relations avec les investisseurs
George Mull
Courriel
info@alternatehealth.ca
Vérificateur
Davidson & Company LLP

Advertisement

Publicité

Capitalisation

Capitalisation: 
91,484,212
Réservé à l'émission: 
8,154,339

Company Officers

Howard Mann, Chief Executive Officer
Chris Boling, Chief Financial Officer
Stephen Bugbee, SVP, Technology
Scott Holtby, VP, Communications
Dr. Robert Blaine, President & Chief Medical Officer

Bulletins

23/06/2020

2020-0637 - Suspensions

Le 23 juin/June 2020

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules.  A Cease Trade Orders have been issued by one or more securities commissions. 

For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca

Advertisement

Publicité

Latest CSE News

Évènements à venir

2020-08-11_TechTues_MedicalDevices_Website

Tech Tuesdays

Mardi, août 11, 2020 -
16:15 - 17:00